[Clinical observations on the effects of the association of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride and oxytetracycline in acute and chronic bronchopathies].
D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000627:therapeutic use*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D005260:Female; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010118:Oxytetracycline / Q000627:therapeutic use*; D011001:Pleuropneumonia / Q000188:drug therapy; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014050:Toluene / Q000627:therapeutic use*
D000814:Aniline Compounds; D000644:Quaternary Ammonium Compounds; D014050:Toluene; D010118:Oxytetracycline
Osservazioni cliniche sugli effetti dell'associazione N-cicloesil-N-metil-(2-amino-3,5-dibromobenzil)-ammonio cloruro e ossitetraciclina nelle broncopneumopatie acute e croniche.